Coordinating Center Wake Forest University School of Medicine
Winston-Salem, NC
3.3.3.
Federal Sponsors Centers for Disease Control and Prevention, Division of Diabetes Translation,
Atlanta, GA
National Institutes of Health, National Institute of Diabetes and Digestive and Kidney
Diseases,
Bethesda, MD
3.3.4.
Central Laboratory Northwest Lipid Metabolism and Diabetes Research Laboratories
University of Washington
Seattle, WA
SEARCH Phase 3 Protocol - Section 4A
Registry Study
Study Objectives & Background and Significance
Table of Contents